OMAHA, Neb.–Transgenomic, Inc. (TBIO) (OTCQB: TBIO) today reported that trading in its shares will begin on the OTCQB exchange under the ticker “TBIO” effective at the open of business on February 22, 2017. On February 17, 2017, the Company received written notification from the staff of the Nasdaq Stock Market LLC (“Nasdaq”) that it had […]
Investors include HBM Genomics and Viking Global Investors Company to expand commercial efforts for its proprietary primary cell culture platform across cancer, stem cell, immunology, cell manufacturing, cell therapy, and regenerative medicine applications SAN FRANCISCO—-Xcell Biosciences announced today the company has closed a $12 million Series A private equity financing round. The financing was led […]
SANTA FE SPRINGS, Calif. Applied BioCode is pleased to announce that they have been accepted for listing on the Taiwan Emerging Market Stock Exchange (ticker symbol 6598). As a registered Cayman Island corporation with facilities in the United States and Taiwan, Applied BioCode designs, develops, and commercializes innovative high value automated products for the Molecular […]
BALTIMORE, MD — Circulomics has been awarded a $1.5M SBIR Phase II grant by the National Institutes of Health (NIH)/National Institute of General Medical Sciences (NIGMS) to develop a single molecule platform for DNA/RNA sample quality analysis based on PicoSep technology. PicoSep is a single molecule instrument that can perform accurate sizing and quantification of DNA/RNA […]
Life sciences company awarded Small Business Innovation Research (SBIR) Grant from National Cancer Institute Branford, Conn. IsoPlexis Corporation (IsoPlexis), a venture-capital funded life sciences company developing an innovative cellular response analysis platform to measure the proteomic function of individual cells in patients, today announced it was recently awarded a competitive Phase I Small Business Innovation […]
Eden Prairie, Minn. – MTS Systems Corporation (NASDAQ: MTSC) (the “Company”), a leading global supplier of high-performance test systems and sensors, today announced that the lenders under its current credit agreement have waived any default that would have resulted from failure to provide the Company’s audited financial statements for the fiscal year ended October 1, 2016 (“Fiscal […]
ROCHESTER, NY and ST LOUIS, MO – Adarza BioSystems, Inc., a leading next generation innovator in label-free, multiplex assays, announced today that it has closed a $17M Series C financing. Proceeds from the financing will be used to further expand production capacity in its St. Peters, MO manufacturing facility and fund final development and commercialization […]
MENLO PARK, Calif. — Synthomics, Inc., an emerging developer of next-generation systems for oligonucleotide synthesis, announced today that it has completed seed round financing and has launched an early access program for its end-to-end DNA synthesis platform. The financing round was anchored by TEEC Angel Fund (https://www.teec-angel.com), a Palo Alto, CA-based Micro VC fund with an […]
Ghent, Belgium PharmaFluidics NV, a game-changing innovator in the field of analytical chromatography, announced today that it has raised 2.7 million euro of additional funding. The funding was subscribed by a consortium of PharmaFluidics’ existing shareholders, new investors and management. Shareholders include Qbic Arkiv Fund, the Flemish investment company PMV, Theodorus Fund, Innovation Fund and […]
Adjustment to capital structure through reduction in number of shares outstanding and direct capital repayment set for completion in January 2017 Venlo, the Netherlands – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) (the “Company”) today announced details for completion of a synthetic share repurchase plan that combines a direct capital repayment with a reverse stock […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
